The latter was not observed when using neutrophils that lacked CD16b expression (isolated from paroxysmal nocturnal hemoglobinuria patients) [104], again pointing toward the inhibitory function of CD16b that may be exacerbated upon antibody engineering. This evidence concerns the gene FCGR3B and paroxysmal nocturnal hemoglobinuria.